TB Alliance And BG Medicine Initiate Biomarker Discovery Program
NEW YORK and WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 21, 2006--The Global Alliance for TB Drug Development (TB Alliance) and BG Medicine Inc. announced today a collaboration to identify biomarkers for drug efficacy in the treatment of tuberculosis (TB), a step toward faster and more efficient drug development.